UK Rapid Test Consortium explained

The UK Rapid Test Consortium (UK-RTC) is a United Kingdom industry consortium created to produce a lateral flow rapid test for COVID-19. Rapid tests are a form of COVID-19 testing technology that was originally developed from significant investment by the United Kingdom government to develop new forms of COVID-19 testing that provided advantages over existing forms such as PCR. Its members include Abingdon Health, BBI Solutions, CIGA Healthcare, Omega Diagnostics, and Oxford University.[1] [2]

In 2020, the consortium developed the AbC-19 rapid antibody test to meet UK government requirements.[2] The government ordered 1 million of the UK-RTC's rapid tests in October 2020.[3]

CIGA Healthcare was made responsible for assembly and distribution, and was awarded distribution to the United States in November 2020 after approval was given by the FDA.[4]

Notes and References

  1. Web site: rapidmicrobiology UK Begin At-Home COVID-19 Antibody Testing Programme. 2020-11-13. www.rapidmicrobiology.com.
  2. Web site: Industry responds to call to arms to build British diagnostics industry at scale. 2020-11-13. GOV.UK. en.
  3. Web site: Government invests in UK-developed antibody tests from UK Rapid Test Consortium. 2020-11-13. GOV.UK. en.
  4. Web site: Yorkshire developed Covid-19 test approved for use in North America. en.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "UK Rapid Test Consortium".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.